Accuray ROA 2006-2018 | ARAY

Current and historical return on assets (ROA) values for Accuray (ARAY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Accuray ROA for the three months ending June 30, 2018 was -5.26%.
Accuray Annual ROA
2018 -6.31
2017 -7.28
2016 -5.44
2015 -8.61
2014 -7.16
2013 -20.46
2012 -15.08
2011 -5.85
2010 1.08
2009 0.22
2008 1.83
2007 -1.94
2006 -24.31
2005 0.00
Accuray Quarterly ROA
Q4 2018 -0.25
Q3 2018 -2.29
Q2 2017 -1.14
Q1 2017 -2.38
Q4 2017 -1.29
Q3 2017 -1.21
Q2 2016 -2.26
Q1 2016 -2.35
Q4 2016 -1.54
Q3 2016 0.15
Q2 2015 -1.27
Q1 2015 -2.82
Q4 2015 -1.20
Q3 2015 -0.64
Q2 2014 -2.14
Q1 2014 -4.71
Q4 2014 -1.98
Q3 2014 -0.95
Q2 2013 -1.12
Q1 2013 -3.28
Q4 2013 -3.93
Q3 2013 -6.28
Q2 2012 -6.14
Q1 2012 -5.01
Q4 2012 -3.85
Q3 2012 -3.00
Q2 2011 -2.09
Q1 2011 -5.62
Q4 2011 -5.48
Q3 2011 -0.44
Q2 2010 1.60
Q1 2010 -1.83
Q4 2010 1.91
Q3 2010 0.88
Q2 2009 -0.45
Q1 2009 -1.27
Q4 2009 0.45
Q3 2009 0.45
Q2 2008 0.47
Q1 2008 -1.13
Q4 2008 0.07
Q3 2008 0.20
Q2 2007 0.76
Q1 2007 0.71
Q4 2007 0.15
Q3 2007 -0.25
Q2 2006 -5.07
Q1 2006 0.00
Q3 2006 0.00
Q2 2005 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.355B $0.405B
ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 40,000 patients worldwide and currently more than 130 systems have been installed in leading hospitals in the Americas, Europe and Asia.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $98.077B 23.53
Intuitive Surgical (ISRG) United States $63.331B 60.45
Edwards Lifesciences (EW) United States $32.178B 36.24
Fresenius Medical Care (FMS) Germany $31.319B 22.12
IDEXX Laboratories (IDXX) United States $20.880B 63.46
ABIOMED (ABMD) United States $17.272B 141.50
Teleflex (TFX) United States $12.353B 29.39
DexCom (DXCM) United States $12.326B 0.00
Hologic (HOLX) United States $11.222B 19.09
Varian Medical Systems (VAR) United States $10.297B 25.92
STERIS (STE) United Kingdom $9.636B 26.50
Masimo (MASI) United States $6.344B 42.24
LivaNova (LIVN) United Kingdom $5.944B 35.46
Inogen (INGN) United States $5.438B 143.90
Integra LifeSciences Holdings (IART) United States $5.381B 27.85
Globus Medical (GMED) United States $5.316B 35.36
Penumbra (PEN) United States $5.135B 466.72
Cantel Medical (CMD) United States $4.058B 42.30
Halyard Health (AVNS) United States $3.231B 26.59
Wright Medical Group (WMGI) Netherlands $2.988B 0.00
Integer Holdings (ITGR) United States $2.683B 24.29
Opko Health (OPK) United States $2.418B 0.00
Tandem Diabetes Care (TNDM) United States $2.320B 0.00
Glaukos (GKOS) United States $2.054B 1176.80
Nevro (NVRO) United States $1.784B 0.00
Mazor Robotics (MZOR) Israel $1.531B 0.00
AxoGen (AXGN) United States $1.374B 0.00
Luminex (LMNX) United States $1.309B 38.62
CryoLife (CRY) United States $1.272B 111.61
Accelerate Diagnostics (AXDX) United States $1.221B 0.00
K2Ms (KTWO) United States $1.190B 0.00
Tactile Systems Technology (TCMD) United States $1.172B 199.72
Natus Medical (BABY) United States $1.152B 24.43
Orthofix (OFIX) United States $1.017B 30.97
Intersect ENT (XENT) United States $0.901B 0.00
AngioDynamics (ANGO) United States $0.872B 32.21
ViewRay (VRAY) United States $0.733B 0.00
Mesa Laboratories (MLAB) United States $0.698B 43.16
Sientra (SIEN) United States $0.692B 0.00
Pacific Biosciences Of California (PACB) United States $0.635B 0.00
Neuronetics (STIM) United States $0.603B 0.00
GenMark Diagnostics (GNMK) United States $0.438B 0.00
OrthoPediatrics (KIDS) United States $0.418B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.415B 0.00
Quotient (QTNT) Switzerland $0.360B 0.00
IRadimed (IRMD) United States $0.357B 128.65
Veracyte (VCYT) United States $0.346B 0.00
Nuvectra (NVTR) United States $0.320B 0.00
Fluidigm (FLDM) United States $0.308B 0.00
RTI Surgical (RTIX) United States $0.282B 55.63
T2 Biosystems (TTOO) United States $0.277B 0.00
Pulse Biosciences (PLSE) United States $0.234B 0.00
SeaSpine Holdings (SPNE) United States $0.234B 0.00
Helius Medical Technologies (HSDT) United States $0.228B 0.00
Invuity (IVTY) United States $0.178B 0.00
Apollo Endosurgery (APEN) United States $0.151B 0.00
Alphatec Holdings (ATEC) United States $0.138B 0.00
Ekso Bionics Holdings (EKSO) United States $0.138B 0.00
Second Sight Medical Products (EYES) United States $0.125B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.124B 0.00
Sensus Healthcare (SRTS) United States $0.120B 0.00
Viveve Medical (VIVE) United States $0.094B 0.00
EDAP TMS (EDAP) France $0.083B 0.00
Restoration Robotics (HAIR) United States $0.077B 0.00
ConforMIS (CFMS) United States $0.075B 0.00
OBALON THERPTCS (OBLN) United States $0.061B 0.00
Neovasc (NVCN) Canada $0.057B 0.00
Vermillion (VRML) United States $0.053B 0.00
PAVmed (PAVM) United States $0.035B 0.00
ReWalk Robotics (RWLK) Israel $0.032B 0.00
Titan Medical (TMDI) Canada $0.032B 0.00
Lianluo Smart (LLIT) China $0.031B 0.00
Presbia (LENS) Ireland $0.030B 0.00
Dynatronics (DYNT) United States $0.023B 0.00
Microbot Medical (MBOT) United States $0.020B 0.00
DarioHealth (DRIO) Israel $0.020B 0.00
Nanovibronix (NAOV) United States $0.017B 0.00
Bioanalytical Systems (BASI) United States $0.017B 0.00
Avinger (AVGR) United States $0.016B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
Allied Healthcare Products (AHPI) United States $0.009B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
Amedica (AMDA) United States $0.003B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00